1 May 2014 in G3: Genes, Genomes, Genetics
Bacterial Cas9 nuclease induces site-specific DNA breaks using small gRNA as guides. Cas9 has been successfully introduced into Drosophila for genome editing. Here, we improve the versatility of this method by developing a transgenic system that expresses Cas9 in the Drosophila germline. Using this system, we induced inheritable knock-out mutations by injecting only the gRNA into embryos, achieved highly efficient mutagenesis by expressing gRNA from the promoter of a novel non-coding RNA gene, and recovered homologous recombination-based knock-in of a fluorescent marker at a rate of 4.5% by co-injecting gRNA with a circular DNA donor.
28 August 2024 in Oncogene
19 January 2026 in Nature Communications
Although multiple cellular pathways have been implicated in α-Synuclein (α-syn)-associated Parkinson’s disease (PD), the role of lipid metabolism remains elusive. In this study, we identify Drosophila mino, which encodes the mitochondrial isoform of the lipid synthesis enzyme glycerol 3-phosphate acyltransferase (GPAT), as a potent modifier of α-syn. Silencing the expression of mino significantly suppresses α-syn-induced PD phenotypes in Drosophila, including dopaminergic neuronal loss and locomotion defects as well as circadian rhythm-related activities, whereas mino overexpression yields opposite effects. Mechanistically, we find that mino modulates the levels of mitochondrial reactive oxygen species and lipid peroxidation. Importantly, treatment of α-syn-expressing flies with FSG67, a GPAT inhibitor of glycerol 3-phosphate acyltransferase, reproduces the benefits of mino knockdown. FSG67 also inhibits α-syn aggregation and lipid peroxidation in mouse primary neurons treated with α-syn preformed fibrils. Our study elucidates an important factor contributing to α-syn toxicity and offers a therapeutic direction for PD.
5 June 2026 in Journal of Visualized Experiments
Drosophila melanogaster serves as a powerful model organism for studying neurodegenerative diseases, including Parkinson's disease (PD), primarily through the analysis of dopaminergic (DA) neuron degeneration and associated locomotion deficits. Historically, quantification of DA neuron loss in the fly brain has been confined to smaller, readily countable clusters, including protocerebral posterior medial (PPM) clusters and protocerebral posterior lateral (PPL) clusters. In contrast, the substantially larger protocerebral anterior medial (PAM) cluster, comprising over 100 neurons, presents a significant challenge for manual counting, leading to its underrepresentation in quantitative studies. To date, reported investigations still rely on labor-intensive manual counts through confocal Z-stacks, which are time-consuming and prone to variability. To address this methodological gap, we developed a semi-automated image analysis pipeline using the open-source tool Labkit. This protocol enables efficient group-relative quantification of tyrosine hydroxylase (TH)-positive neurons in the PAM cluster within the same experimental batch. The method starts with standard immunofluorescence staining and confocal imaging, followed by a detailed, step-by-step guide for segmentation and analysis. This approach addresses the bottleneck of PAM cluster quantification and provides a practical workflow for detecting intergroup differences in DA neuron vulnerability in models of neurodegeneration. The relative scarcity of PD studies on the PAM cluster reflects a historical technical barrier rather than a lack of biological relevance. By overcoming this barrier, our method opens the door to systematic investigation of PAM neuron vulnerability in PD and its potential link to non-motor symptoms.